GlassScriptPhysician profile
Richard S Duff
NPI 1699868612
$1,138.48
in general payments reported to CMS, 2019-2025
20 companies · $445 in 2025
The $445 reported for 2025 was more than what 78% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $40.40 · 2020: $28.24 · 2022: $111 · 2023: $223 · 2024: $291 · 2025: $445.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $959.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $959.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $215.03 | 2023-2025 | Ova1 |
| Astellas Pharma US INC | $174.84 | 2024-2025 | Veozah |
| Hologic Sales and Service, LLC | $135.36 | 2020-2025 | Aptima, Thinprep 2000 Processor, Myosure Tissue Removal Device |
| Coopersurgical, INC. | $83.63 | 2024-2025 | Endosee, Paragard T 380a |
| Novo Nordisk INC | $78.58 | 2022-2024 | Wegovy |
| Organon LLC | $64.14 | 2023-2025 | Nexplanon, Jada System |
| Sumitomo Pharma America, INC. | $58.11 | 2024-2025 | Myfembree |
| Shield Therapeutics INC | $57.28 | 2023-2024 | Accrufer |
| Exeltis, USA INC. | $52.92 | 2024-2025 | Slynd |
| Therapeuticsmd, INC. | $39.58 | 2019-2020 | |
| Meditrina | $26.68 | 2024-2025 | |
| Mimedx Group, INC. | $24.93 | 2024 | |
| Biogen, INC. | $24.42 | 2024 | |
| Smith+Nephew, INC. | $22.01 | 2022 | |
| Medtronic, INC. | $21.37 | 2023 | Truclear |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $19.50 | 2022 | |
| Covidien LP | $14.14 | 2019 | |
| Lilly USA, LLC | $14.13 | 2025 | Zepbound |
| Scynexis, INC. | $11.83 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Duff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.